Related Experiment Video
Updated: Jul 13, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Gender and chronic obstructive pulmonary disease: why it matters
Meilan K Han1, Dirkje Postma, David M Mannino
1Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA.
American Journal of Respiratory and Critical Care Medicine
|August 4, 2007
Summary
Chronic obstructive pulmonary disease (COPD) affects more women, yet they are diagnosed less often. Women may face greater risks from smoking and unique disease presentations, requiring further research into gender-specific treatments.
Area of Science:
- Pulmonology
- Epidemiology
- Gender Studies
Background:
- Increasing prevalence and mortality of chronic obstructive pulmonary disease (COPD) in women globally.
- Disparities in COPD diagnosis rates between men and women, with women being underdiagnosed.
- Women exhibit heightened susceptibility to smoking-induced lung function decline and more severe symptoms.
Discussion:
- Investigating the biological, physiological, and sociological factors contributing to gender differences in COPD.
- Exploring potential phenotypic variations in COPD presentation between sexes, such as emphysematous versus airway-predominant disease.
- Considering the role of sexual dimorphism in immune responses in the context of COPD pathogenesis.
Key Insights:
- Women with COPD are more likely to be non-smokers.
- Emerging evidence suggests distinct responses to tobacco smoke exposure in men and women.
- Gender influences COPD epidemiology, diagnosis, and clinical presentation.
Outlook:
- Need for further research into the implications of gender on COPD therapy.
- Understanding gender-specific nuances in COPD is crucial for optimizing patient management.
- Future studies should focus on sex-based differences in COPD pathophysiology and treatment response.
Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation